Simplify Logo

Full-Time

Director of Business Development

Pharma and Drug Discovery

Posted on 7/9/2024

Parse Biosciences

Parse Biosciences

51-200 employees

Provides single-cell analysis tools and software

Data & Analytics
Hardware
Biotechnology

Compensation Overview

$175k - $210kAnnually

+ Equity Grants

Expert

Remote in USA

Category
Business Development
Business & Strategy
Required Skills
Market Research
Sales
Communications
Data Analysis
Requirements
  • Bachelor's degree in Life Sciences, Business Administration, or related field; MBA or PhD, or related advanced degree preferred.
  • 10+ years of proven experience in business development or sales within the life sciences industry
  • Strong understanding of life sciences markets, including pharmaceuticals, biotechnology, medical devices, or related sectors
  • Strong relationships within the industry and pharma research
  • Knowledge of Clinical Workflows, a plus
  • Demonstrated expertise in drug discovery workflows with a preference toward oncology and immunology
  • Exceptional negotiation, communication, and interpersonal skills
  • Strategic thinking with excellent analytical abilities
  • Proven ability to work independently, manage multiple projects simultaneously
  • Proficiency in Microsoft Office Suite and CRM software; familiarity with data analysis tools is a plus
  • Willingness to travel as needed, as much as 30% of the time
Responsibilities
  • Develop Key pharma account business plans
  • Identify and evaluate new business opportunities
  • Develop and execute strategic plans to drive revenue growth
  • Build and nurture relationships with key account stakeholders
  • Lead negotiations, prepare proposals, and manage the entire sales cycle
  • Conduct market research and analysis
  • Collaborate cross-functionally with internal teams
  • Represent the company at industry events, conferences, and meetings
  • Prepare and present reports, forecasts, and updates to senior management

Parse Biosciences focuses on advancing single-cell research by providing solutions that allow scientists to analyze individual cells with high precision. Their unique technology, called "split-pool combinatorial barcoding," enables scalable single-cell analysis without the need for expensive custom instruments. The company offers an end-to-end solution that includes preparing cell or nuclei suspensions, sequencing, and data analysis, all supported by their proprietary software, Trailmaker. Unlike competitors, Parse Biosciences emphasizes accessibility and scalability in their products, making advanced single-cell analysis available to a wider range of researchers and institutions. The company's goal is to push the boundaries of single-cell science and support researchers in pioneering new areas of inquiry.

Company Stage

Series C

Total Funding

$99.9M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

5%

1 year growth

25%

2 year growth

101%
Simplify Jobs

Simplify's Take

What believers are saying

  • The Certified Service Provider and Laboratory Automation Provider programs can significantly expand Parse Biosciences' market reach and operational efficiency.
  • The Evercode BCR and TCR product lines offer unprecedented resolution and scalability, opening new avenues for antibody discovery and immune profiling.
  • Their subscription-based software model ensures a steady revenue stream while supporting continuous innovation and client needs.

What critics are saying

  • The rapidly evolving biotechnology market requires constant innovation, posing a risk if Parse Biosciences fails to keep pace with competitors.
  • Dependence on the success of their proprietary technologies like Trailmaker and Evercode could be a vulnerability if these solutions face technical or market acceptance issues.

What makes Parse Biosciences unique

  • Parse Biosciences leverages split-pool combinatorial barcoding, enabling scalable single-cell analysis without expensive custom instruments, unlike many competitors.
  • Their end-to-end solution, including the Trailmaker software, offers a comprehensive package from cell preparation to data analysis, setting them apart from companies that provide only partial solutions.
  • The recent launch of Evercode BCR and expansion of Evercode TCR products highlight their commitment to innovation and ability to capture the immense diversity of immune repertoires.
INACTIVE